Pre-Market Stock Notes (DEC 27, 2006)

(AAPL) Apple’s options probe apparently has potential faked documentation.
(BA) Boeing won a $1.5 Billion contract for Apache helicopters.
(BIOV) BioVeris announces license agreement with Baxter on meningitis.
(BMY) Bristol-Myers Squibb announces licensing agreement with Otsuka Pharma in Japan on Type II Diabetes.
(BSG) BYSIS is reportedly considrring going private afterrecent troubles.
(CANM) Caneum was in a bid win team for part of a $5B government purchase contract.
(CDMS) Cadmus gets $24.75 buyout from Cenveo.
(CRXL) Crucell in cross-license pact with Merck.
(GVA) Granite Construction is part of a $420M highway contract win.
(HSP) Hospira launches generic version of Glaxosmithkline-GSK’s Zofran for cancer chemo nausea.
(KNTA) Kintera filed to sell 4M shares for holders.
(MNI) McClatchy agreed to sell the Star Tribune paper in Minneapolis for $530M.
(MNST) Monster Worldwide said it has completed all filings now to become current; will record $5M in one-time expenses.
(MRX) Medicis wins injectable wrinkle treatment approval from FDA.
(NBR) Nabors is reviewing stock options.
(OMRI) Omrix Biopharma files IND application with the FDA; received milestones.
(ULBI) Ultralife Batteries won $2.9M military battery contract.
(UNH) United Health options probe from SEC is now formal.

Jon C. Ogg
December 27, 2006